SKI Market

Indian Indices

Sensex

82,814.71 316.57
( 0.38%)

Global Indices

Nasdaq

49,649.56 233.39
(0.47%)

Dow Jones

6,930.29 47.40
(0.69%)

Hang Seng

56,838.27 -629.56
(-1.10%)

Nikkei 225

10,691.66 64.62
(0.61%)

Forex

USD-INR

91.03 0.34
(0.37%)

EUR-INR

107.23 0.00
(0.00%)

GBP-INR

122.67 -0.16
(-0.13%)

JPY-INR

0.59 0.00
(-0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gennex Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

531739

INE509C01026

8.6694335

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

18.85

284.01

EPS(TTM)

Face Value()

Div & Yield %

0.62

Back

Authum Investment & Infrastructure consolidated net profit declines 70.15% in the December 2025 quarter

Feb 11,2026

Net profit of Authum Investment & Infrastructure declined 70.15% to Rs 161.00 crore in the quarter ended December 2025 as against Rs 539.41 crore during the previous quarter ended December 2024. Sales declined 22.51% to Rs 478.04 crore in the quarter ended December 2025 as against Rs 616.94 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	478.04	616.94	-23
OPM %	74.36	101.14	-
PBDT	286.02	617.03	-54
PBT	278.40	613.58	-55
NP	161.00	539.41	-70

82,814.71 316.57 ( 0.38%)

49,649.56 233.39 (0.47%)

6,930.29 47.40 (0.69%)

56,838.27 -629.56 (-1.10%)

10,691.66 64.62 (0.61%)

91.03 0.34 (0.37%)

107.23 0.00 (0.00%)

122.67 -0.16 (-0.13%)

0.59 0.00 (-0.25%)